Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dCjCCrsecrtCwicNKqHH

  ADVERTISEMENT  
April 19, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  Science & Health 
  • Researchers use stem cells to regrow hair in bald mice
    Japanese researchers used epithelial stem cells and mesenchymal cells to engineer hair follicles that grew like normal hair when implanted in bald mice. The development may help in the regeneration of organs such as salivary glands, which grow in the same way as hair in their early development, a researcher said. The findings were published in the journal Nature Communications. Science News (4/18) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
 
  ADVERTISEMENT  
Donor Recruiting & Retention is About to Get Easier
According to a recent study by Harris Interactive, nearly two-thirds of consumers now obtain information about products, brands, destinations and so much more – while they're on the go. In fact, a shocking number search — and act — based on their current location. Get ready for the future of donor recruiting and retention. Learn more.

  Industry News & Practice 
  Government & Regulatory 
  • Senate bill aims for FDA reform
    Sens. Tom Coburn, R-Okla., and Richard Burr, R-N.C., introduced a bill aimed at improving the FDA's internal management as well as accountability in regulating drugs and medical devices. The Patients' FDA Act would relax restrictions on companies' ties with physicians and speed up product-approval review. The proposal is meant to be part of the Prescription Drug and User Fee Act reauthorization. Forbes/The Apothecary blog (4/18) LinkedInFacebookTwitterEmail this Story
  • Chief innovation officer would improve FDA, group says
    The FDA needs an official who can examine whether the agency's drug rejections are justified and whether long waits discourage innovation, BIO President and CEO Jim Greenwood said. During the reauthorization process for the Prescription Drug User Fee Act, BIO also has supported the expansion of accelerated drug approvals and revival of informal talks between FDA and companies. American City Business Journals/Boston (4/18) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: Proposals due tomorrow for AABB 2013 audioconference series
    AABB's Distance Learning Program Unit is soliciting educational program proposals for the 2013 audioconference series. Proposals should suggest 60-minute programs that focus on technical/clinical, scientific, quality/education, cellular therapies and leadership management. Individuals who would like to participate should complete the audioconference program proposal form and e-mail it to the AABB Education and Professional Development department or send it via fax to +1.301.951.3729. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
(CEO), Greater Ozarks RegionAmerican Red CrossUS - AR - Little Rock
Country Director - MozambiqueAABBMOZ - Nationwide
Transfusion Safety CoordinatorPacific Diagnostic Laboratories, LLCUS - CA - Santa Barbara
Standards Development SpecialistAABBUS - MD - Bethesda
Deputy Director, Regulatory Affairs - Cellular TherapyAABBUS - MD - Bethesda
Click here to view more job listings.

  SmartQuote 
Things alter for the worse spontaneously, if they be not altered for the better designedly."
--Francis Bacon,
British author and statesman


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor:  Aaron Lyss
   
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information